We have data on 376 companies that use NeuroLogica. The companies using NeuroLogica are most often found in United States and in the Hospital & Health Care industry. NeuroLogica is most often used by companies with 1000-5000 employees and >1000M dollars in revenue. Our data for NeuroLogica usage goes back as far as 5 years and 1 months.
|Company||Racepoint Global, Inc.|
|Company||University of Washington Medical Center|
|Company||Koninklijke Philips NV|
|Racepoint Global, Inc.||racepointglobal.com||United States||10M-50M||50-200|
|University of Washington Medical Center||uwmedicine.org||United States||>1000M||50-200|
|Koninklijke Philips NV||philips.nl||Netherlands||>1000M||>10000|
We use the best indexing techniques combined with advanced data science to monitor the market share of over 15,000 technology products, including Medical Devices. By scanning billions of public documents, we are able to collect deep insights on every company, with over 100 data fields per company at an average. In the Medical Devices category, NeuroLogica has a market share of about 3.0%. Other major and competing products in this category include:
NeuroLogica, a healthcare subsidiary of Samsung Electronics Co., Ltd., develops, manufactures, and markets innovative imaging technologies and is committed to delivering fast, easy and accurate diagnostic solutions to healthcare providers.
Looking at NeuroLogica customers by industry, we find that Hospital & Health Care (32%), Pharmaceuticals (12%), Higher Education (10%) and Medical Devices (5%) are the largest segments.
35% of NeuroLogica customers are in United States, 22% are in Italy, 6% are in Spain and 5% are in Brazil.
Of all the customers that are using NeuroLogica, 21% are small (<50 employees), 32% are medium-sized and 47% are large (>1000 employees).
Of all the customers that are using NeuroLogica, 41% are small (<$50M), 11% are medium-sized and 39% are large (>$1000M).